Marsh & McLennan Companies, Inc. (MMC) reported fourth-quarter 2024 adjusted earnings per share of $1.87, which beat the Zacks Consensus Estimate by 6.9%. The bottom line increased 11% year over year. See the Zacks Earnings Calendar to stay ahead of market-making news.Consolidated revenues rose 9.4% year over year to $6.1 billion. The figure also improved 7% on an underlying basis. The top line surpassed the consensus mark by 2.5%.The strong quarterly earnings benefited from strong United States/Canada and ...

For the quarter ended December 2024, Marsh & McLennan (MMC) reported revenue of $6.07 billion, up 9.2% over the same period last year. EPS came in at $1.87, compared to $1.68 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $5.92 billion, representing a surprise of +2.54%. The company delivered an EPS surprise of +6.86%, with the consensus EPS estimate being $1.75.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and h ...

Marsh & McLennan (MMC) came out with quarterly earnings of $1.87 per share, beating the Zacks Consensus Estimate of $1.75 per share. This compares to earnings of $1.68 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 6.86%. A quarter ago, it was expected that this global professional services firm providing strategy, risk and people solutions would post earnings of $1.61 per share when it actually produced earnings of $1.63, de ...

Marsh McLennan 1166 Avenue of the Americas New York, New York 10036-2774 212 345 5000 www.marshmclennan.com News release Exhibit 99.1 Marsh McLennan reports strong fourth quarter and full-year 2024 results NEW YORK, January 30, 2025 – Marsh McLennan (NYSE: MMC), the world's leading professional services firm in the areas of risk, strategy and people, today reported financial results for the fourth quarter and year ended December 31, 2024. John Doyle, President and CEO, said: "Our fourth quarter results capp ...

Marsh & McLennan Companies, Inc. (MMC) is scheduled to release fourth-quarter 2024 results on Jan. 30, before the opening bell. The Zacks Consensus Estimate for the quarterly earnings per share is pegged at $1.75, which indicates a 4.2% rise from the prior-year quarter’s number. See the Zacks Earnings Calendar to stay ahead of market-making news.The fourth-quarter earnings estimate has moved south by a cent over the past 30 days. Meanwhile, the Zacks Consensus Estimate for revenues is pegged at $5.9 billion ...

The market expects Marsh & McLennan (MMC) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The earnings report, which is expected to be released on January 30, 2025, might help the stock move higher if these key numb ...

Marsh & McLennan Companies, Inc. (MMC) , operating in the insurance brokerage space, is currently considered relatively overvalued, trading at a trailing 12-month price/book (P/B) of 7.47X. This figure is higher than the broader Insurance- Brokerage average of 6.72X. Other industry players, such as Arthur J. Gallagher & Co. (AJG) and Brown & Brown, Inc. (BRO) , are trading at 5.74X and 4.48X P/B, respectively. Given MMC’s premium valuation, we need to carefully assess this stock’s key drivers and growth pro ...

Acquisition and Strategic Growth - Marsh McLennan Agency (MMA) acquired Acumen Solutions Group LLC, a full-service insurance agency specializing in construction, real estate, and aviation sectors, to deepen expertise and expand its client base [1] - The acquisition strengthens MMA's presence in the Northeast market and enriches its service portfolio, leveraging Acumen's specialized knowledge and Marsh McLennan's resources [2] - This move positions MMA as a stronger player in the competitive insurance sector, following the acquisition of McGriff Insurance Services in November 2024, which enhanced capabilities in the middle-market segment [3] - Acquisitions are a key pillar of Marsh & McLennan's growth strategy, with $1 billion spent on acquisitions in the first nine months of 2024, up from $619 million in the prior-year period [4] Financial Performance and Market Position - Marsh revenues grew 9% year over year in the third quarter of 2024, driven by strategic acquisitions and enhanced service offerings [2] - Shares of Marsh & McLennan gained 10.4% in the past year, underperforming the industry's 27.3% growth [5] Industry Comparison and Peer Performance - Horace Mann Educators Corporation (HMN) is expected to see a 66.2% rise in 2024 earnings and a 7.6% improvement in revenues, with an average earnings surprise of 4.6% in the last four quarters [8] - Brown & Brown, Inc. (BRO) is projected to achieve a 33.1% increase in 2024 earnings and an 11.2% rise in revenues, with an average earnings surprise of 6.87% in the last four quarters [9] - Radian Group Inc. (RDN) is anticipated to experience a 3.1% growth in 2024 earnings and a 6.4% improvement in revenues, with an average earnings surprise of 17.65% in the last four quarters [10]

Marsh & McLennan Companies, Inc. (MMC) is well-poised for growth on the back of sustained revenue increase, new business growth, frequent buyouts and adequate cash-generating abilities.MMC’s Zacks Rank & Price RallyMarsh & McLennan currently carries a Zacks Rank #3 (Hold).The stock has gained 18.1% in the past year.Image Source: Zacks Investment ResearchMMC’s Robust Growth ProspectsThe Zacks Consensus Estimate for Marsh & McLennan’s 2024 earnings is pegged at $8.68 per share, indicating a 8.6% increase from ...

Octaviant Financial Announces Strategic Initiative with Starr InsuranceNovember 21, 2024 12:26 PM EST | Source: Reportable, Inc.New Brunswick, New Jersey--(Newsfile Corp. - November 21, 2024) - Octaviant Financial, Inc. (OFX), a recognized innovator in drug warranty and payment models, announced today that Starr Insurance will join Octaviant and Marsh, the world’s leading insurance broker and risk advisor, in offering drug warranty services that enable pharmaceutical companies to stand behind ...